Catalyst Wire Dossier Catalyst Wire Dossier

Carvedilol Tablets USP 12.5 mg

carvedilol · IPCA Laboratories Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carvedilol Tablets USP 12.5 mg, covering 2012-07-09 to 2012-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition [Phase 1]

See pricing